Clinical trial
Effectiveness and Safety of Treatment With Vedolizumab in Adult Patients With Ulcerative Colitis or Crohn's Disease in Real Life
NCT03378388 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Treatment With Vedolizumab in Adult Patients With Ulcerative Colitis or Crohn's Disease in Real Life
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 13, 2018
- Completion date
- February 15, 2019
- Enrollment
- 29 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.